Skip to content
Screener

Phibro Animal Health PAHC Performance Products — Revenue

Other segment segments

Animal Health
$291.23M+12.7%
Mineral Nutrition
$73.42M+9.9%

Similar metrics at other companies

CSP logo
CSPIHigh Performance Products — Revenue
$348K-46.2%
Huntsman logo
HUNPerformance Products — Revenue
$228M-11.3%
GigaCloud Technology logo
GCTProduct revenues — Revenue
$290.82M+28.9%
Nine Energy Service logo
NINEProduct revenues — Revenue
$45.59M+23.1%
Cabot Corporation logo
CBTPerformance Chemicals — Revenue
$328M+5.5%
Blue Owl Capital logo
OWLPerformance revenues — Revenue
$6.07M-3.9%

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.44B+20.2%
Enterprise value$1.42B+19.2%
P/E15.1×-9.7×
P/S0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Phibro Animal Health’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:25 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056280
For the Periods Ended March 31Three Months / 2026Three Months / 2025Nine Months / 2026Nine Months / 2025
Animal Health
MFAs and other$205,789$181,645$603,098$439,827
Nutritional specialties46,81043,350145,191131,908
Vaccines38,62633,382116,36998,583
Total Animal Health$291,225$258,377$864,658$670,318
Mineral Nutrition73,41866,774205,351189,086
Performance Products18,90022,67451,33758,114
Total$383,543$347,825$1,121,346$917,518

Item 1. Financial Statements (unaudited)

FAQ

What is Phibro Animal Health's performance products — revenue?
Phibro Animal Health (PAHC) reported performance products — revenue of $18.9M in Q1 2026.
How has Phibro Animal Health's performance products — revenue changed year-over-year?
Phibro Animal Health's performance products — revenue decreased by 16.6% year-over-year, from $22.67M to $18.9M.
What is the long-term trend for Phibro Animal Health's performance products — revenue?
Over 3 years (2022 to 2025), Phibro Animal Health's performance products — revenue has grown at a 1.9% compound annual growth rate (CAGR), from $75.69M to $80.18M.
What does performance products — revenue mean?
This represents the total income generated by the Performance Products segment from its primary business activities, such as the sale of goods and services. It is the primary indicator of the segment's market success and demand for its product portfolio. Consistent revenue growth is a key driver of the segment's long-term value creation.

Ask your AI about Phibro Animal Health's performance products — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude